Go to deals
Healthcare

Barbican Dental Care has been acquired by Bupa Dental Services

The shareholders of Barbican Dental Care have sold the company to Bupa Dental Services (Bupa), the UK-based international healthcare group. Financial terms of this transaction have not been disclosed.

Barbican Dental Care is a specialist corporate dental business, offering affordable private dental care and corporate dental plans to companies based in the City, West End and Canary Wharf. The 24 surgeries operate from nine sites providing general, specialist and cosmetic dentistry.

Bupa provides international healthcare support and advisory services. This transaction meets Bupa’s strategy to acquire high quality private practices based in locations that are convenient for corporate and business centers.

Neil Sikka, who founded Barbican Dental Care in 1992, said: “I am very excited about the opportunity to grow the business within Bupa Dental Services and look forward to working with Bupa on the initial integration and subsequent expansion of their dental services.”

Oaklins Cavendish, based in the UK, advised the shareholders of Barbican Dental Care in this transaction. The team's specialist commented: “Barbican Dental Care’s unique business-to-business service proposition and high quality, well run private surgeries generated significant interest. Neil has successfully developed the business through his constant focus on the provision of high quality private dental services in state-of-the-art facilities.”

Parties

Talk to the deal team

Lord Leigh of Hurley

Managing Partner
London, United Kingdom
Oaklins Cavendish

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Related deals

MEDIK Hospital Design Group has been acquired by STERIS
Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more
SLT has been acquired by Indutrade
Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more